ANIK
Anika Therapeutics Inc
20.40$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 58.3% | 36.7% | 37.4% | 39.3% | 53.1% | 72.7% | 61.5% | 52.0% | 37.6% | 37.4% | 41.4% | 38.5% | 36.9% | 34.1% | 42.9% | 41.3% | 40.6% | 30.3% | 19.8% | 22.6% | 23.2% | 24.1% | 29.6% | 25.1% | 47.1% | 43.9% | 40.1% | 31.7% | 36.6% | 43.4% | |
| 41.7% | 63.3% | 62.6% | 60.7% | 46.9% | 27.3% | 38.5% | 48.0% | 62.4% | 62.6% | 58.6% | 61.5% | 63.1% | 65.9% | 57.1% | 58.7% | 59.4% | 69.7% | 80.2% | 77.4% | 76.8% | 75.9% | 70.4% | 74.9% | 52.9% | 56.1% | 59.9% | 68.3% | 63.4% | 56.6% | |
| 133.3% | 16.7% | 14.4% | 31.1% | 20.0% | 37.8% | 29.8% | 16.8% | 15.4% | 15.9% | 13.5% | 14.2% | 20.7% | 20.4% | 12.4% | 9.5% | 7.6% | 9.4% | 7.7% | 9.7% | 10.4% | 16.6% | 17.2% | 14.5% | 18.0% | 18.5% | 18.0% | 18.0% | 21.3% | 22.8% | |
| 125.0% | 17.5% | 19.4% | 22.2% | 25.6% | 54.9% | 33.6% | 27.3% | 22.8% | 18.1% | 24.9% | 25.9% | 30.6% | 26.3% | 31.2% | 27.6% | 20.6% | 17.2% | 14.3% | 15.9% | 17.4% | 19.0% | 32.5% | 30.5% | 46.0% | 35.9% | 54.3% | 81.6% | 46.3% | 43.5% | |
| 266.7% | 36.7% | 39.6% | 61.5% | 52.9% | 92.8% | 63.3% | 44.2% | 38.3% | 34.0% | 38.4% | 40.1% | 51.3% | 46.7% | 43.5% | 37.1% | 28.2% | 26.6% | 22.0% | 25.6% | 27.8% | 35.6% | 49.8% | 45.0% | 74.6% | 54.4% | 72.3% | 67.6% | 67.6% | 66.4% | |
| -225.0% | 26.7% | 23.0% | -0.7% | -6.0% | -65.5% | -24.8% | 3.9% | 24.1% | 28.7% | 20.2% | 21.4% | 11.8% | 13.9% | 13.6% | 21.6% | 27.6% | 43.4% | 58.2% | 51.8% | 49.0% | 40.3% | 20.6% | 29.9% | -21.7% | 1.8% | -12.4% | 0.7% | -4.3% | -9.8% | |
| 8.3% | 4.2% | 18.0% | 1.5% | 7.2% | 5.9% | 1.8% | 0.9% | 1.5% | 4.2% | 7.8% | 6.8% | 1.4% | 10.9% | 0.4% | 0.3% | 7.4% | 0.2% | 0.1% | 0.1% | 0.3% | 0.4% | 1.4% | 6.9% | 0.6% | 0.1% | 0.4% | 1.9% | 1.9% | 1.5% | |
| -216.7% | 28.3% | 31.7% | -0.7% | 1.2% | -59.7% | -23.0% | 4.8% | 25.6% | 32.8% | 28.0% | 28.2% | 13.2% | 13.7% | 13.2% | 21.3% | 27.4% | 43.3% | 58.2% | 51.9% | 49.2% | 40.7% | 22.0% | 31.5% | -21.9% | 1.6% | -12.0% | 2.6% | -2.3% | -8.2% | |
| 8.3% | 0.8% | 0.7% | 16.3% | 0.1% | 0.1% | 0.0% | -0.6% | -16.7% | 13.1% | 10.9% | 8.6% | 3.1% | 4.5% | 5.4% | 8.2% | 10.9% | 15.9% | 22.0% | 18.8% | 17.7% | 12.7% | 4.2% | 7.8% | -3.6% | -1.2% | -2.5% | 5.5% | 5.1% | 0.6% | |
| -225.0% | 27.5% | 30.9% | -18.5% | 1.1% | -59.7% | -23.1% | 5.4% | 42.3% | 19.8% | 17.2% | 19.6% | 10.1% | 9.2% | 7.8% | 13.1% | 16.5% | 27.4% | 36.3% | 33.1% | 31.5% | 28.1% | 17.7% | 23.7% | -18.4% | 2.8% | -9.5% | -68.4% | -47.0% | -9.6% | |
| -175.0% | 29.2% | 24.3% | 8.1% | 1.3% | -54.6% | -16.5% | 10.4% | 54.9% | 30.2% | 21.7% | 24.0% | 15.8% | 27.9% | 19.5% | 27.7% | 37.5% | 42.7% | 62.6% | 55.8% | 52.6% | 44.1% | 26.2% | 35.1% | -0.8% | -2.8% | -3.1% | 14.4% | 4.5% | -3.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.